Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer
Position
Chief Technology Officer
Company
Kailera Therapeutics
Description
Kailera Therapeutics has announced the appointment of Nur Nicholson as Chief Technology Officer, effective August 31, 2026. Nur brings nearly three decades of experience in technical operations and manufacturing, which will be crucial as the company advances its obesity pipeline towards commercialization.
Quick answer
Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer (August 11, 2026). Kailera Therapeutics is based in Waltham, Massachusetts, United States.
- Who is the new Chief Technology Officer at Kailera Therapeutics?
- Kailera Therapeutics named Nur Nicholson Chief Technology Officer, announced August 11, 2026.
- What did Kailera Therapeutics announce on August 11, 2026?
- Kailera Therapeutics has announced the appointment of Nur Nicholson as Chief Technology Officer, effective August 31, 2026. Nur brings nearly three decades of experience in technical operations and manufacturing, which will be crucial as the company advances its obesity pipeline towards commercialization.
- Where did Nur Nicholson work before joining Kailera Therapeutics?
- Nur Nicholson joins from Apellis Pharmaceuticals.
- What does Kailera Therapeutics do?
- Kailera Therapeutics (Kailera) is developing a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity.
- Where is Kailera Therapeutics based?
- Kailera Therapeutics is based in Waltham, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Versa Vascular (August 11, 2026), Quantitative Biosciences Institute (August 11, 2026), City Therapeutics (August 11, 2026) and Kalohexis (August 11, 2026) also announced leadership changes within 45 days of Kailera Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Biotechnology and Health Care
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Versa Vascular Appoints Bill Shields as Chief Executive Officer (August 11, 2026)
- Quantitative Biosciences Institute Names Brad Schneider as Chief Operating Officer (August 11, 2026)
- City Therapeutics Appoints Keith Regnante as Chief Financial Officer and Mary Beth DeLena as Chief Legal Officer (August 11, 2026)
- Kalohexis Appoints Jeffrey Sherman as Chief Medical Officer (August 11, 2026)
- TurningPoint Healthcare Solutions Appoints Sue Schick as Chief Executive Officer (August 11, 2026)
- Ember LifeSciences Appoints James Braithwaite as Chief Product Officer (August 11, 2026)
Who to call at Kailera Therapeutics, and when
A new leader at Kailera Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Kailera Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kailera Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kailera Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kailera Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Kailera Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.